Page 2 - Lisa Sher News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Salarius Pharmaceuticals : Announces $2 3 Million Registered Direct Offering - Form 8-K

Salarius Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options, today announced that it has entered into. | April 22, 2022

New yorkUnited statesJohanna bennettLisa sherTiberend strategic advisors incLadenburg thalmann co incExchange commissionSalarius pharmaceuticals incProspectus departmentLadenburg thalmann coSalarius pharmaceuticalsRegistered direct offeringLadenburg thalmannSecurities actSecurities litigation reform actStrategic advisors

Salarius Pharmaceuticals, Inc Announces $2 3 Million Registered Direct Offering

Salarius Pharmaceuticals, Inc Announces $2 3 Million Registered Direct Offering
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJohanna bennettLisa sherTiberend strategic advisors incLadenburg thalmann co incExchange commissionSalarius pharmaceuticals incProspectus departmentLadenburg thalmann coSalarius pharmaceuticalsLadenburg thalmannSecurities actSecurities litigation reform actStrategic advisors

Coeptis Therapeutics, Inc and Bull Horn Holdings Corp Announce Merger Agreement

/PRNewswire/ Coeptis Therapeutics, Inc. (OTC PINK: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy.

United statesBritish virgin islandsKarolinska institutetDavid mehalickLisa sherChris caliseDavid schemeliaTiberend strategic advisors incVygen bio incBull horn holdings corpMeister seelig feinCoeptis therapeutics incEllenoff grossman scholeExchange commissionPrnewswire coeptis therapeutics incCoeptis pharmaceuticals inc

BridGene Biosciences Announces Acceptance of Two Abstracts for Poster Presentations at Cambridge Health Institute s Inaugural Drug Discovery Chemistry Conference

/PRNewswire/ BridGene Biosciences, Inc., a biotechnology company using a unique chemoproteomic technology to discover and develop small molecules for high.

United statesSan diegoUnited kingdomSteve luoDave schemeliaVivian zhangHenry johnsonShirley guoCindy huangLisa sherBridgene biosciencesBiosciences incVigene biosciencesCambridge health instituteInaugural drug discovery chemistry conferenceIsobaric mass tagged affinity characterization

Lakewood-Amedex Enrolls First Patient in Phase 2 Clinical Trial for Patients with Chronic Diabetic Foot Ulcers (cDFU)

/PRNewswire/ Lakewood-Amedex, Inc., a privately held, clinical stage pharmaceutical discovery and development company advancing a broad portfolio of.

United statesSteve parkinsonSumita paulLisa sherFelix sigalHollywood presbyterian medical centerAmedex incCalifornia hospital medical centerResearch development at lakewoodSecond clinical trialLine results expectedCalifornia hospital medicalChief medical officerSenior vice presidentLakewood amedex inc